Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance
- PMID: 40808905
- PMCID: PMC12345048
- DOI: 10.1017/ash.2025.10072
Proportion of carbapenem-resistant Enterobacterales with readily detectable beta-lactam resistance
Conflict of interest statement
EW has received honoraria from Roche Diagnostics and Elsevier. PAR has received funding from Pfizer for a respiratory surveillance program independent of EIP and the reported work.
References
- 
    - Biomerieux. BIOFIRE® Blood Culture Identification 2 (BCID2) Panel, 2024. https://www.biomerieux.com/us/en/our-offer/clinical-products/biofire-blo...Accessed November13, 2024
 
- 
    - Roche Diagnostics. cobas® eplex Blood Culture Identification Panels, 2024. https://diagnostics.roche.com/us/en/products/params/eplex-bcid-panels.html. Accessed November 13, 2024
 
- 
    - Diasorin. VERIGENE® Gram-Negative Blood Culture Test, 2024.https://us.diasorin.com/en/molecular-diagnostics/kits-reagents/verigene-.... Accessed November 13, 2024.
 
- 
    - Karlsson M, Lutgring JD, Ansari U, et al. Molecular characterization of carbapenem-resistant enterobacterales collected in the United States. Microb Drug Resist 2022;28:389–397. - PubMed
 
LinkOut - more resources
- Full Text Sources
